You are here

Article Text

Article menu
Download PDFPDF
DTB commentary
Dapagliflozin in people with chronic kidney disease

Abstract

Commentary on: Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med 2020;383:1436–46.

Series Editor: Dr Teck Khong, DTB Associate Editor, Clinical Pharmacology, St George’s, University of London, UK

  • Health Care Quality, Access, and Evaluation
  • Drug-Related Side Effects and Adverse Reactions

https://doi.org/10.1136/dtb.2023.000022

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.